ARS Investment Partners’s Harmony Biosciences HRMY Stock Holding History

ARS Investment Partners’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$622K	Sell	17,085 -1,120	-6%	-$35.3K	0.03%	117
2026 Q1	$510K	Sell	18,205 -3,000	-14%	-$98.4K	0.03%	114
2025 Q4	$793K	Sell	21,205 -250	-1%	-$8.22K	0.05%	103
2025 Q3	$591K	Sell	21,455 -2,800	-12%	-$96.5K	0.04%	108
2025 Q2	$766K	Sell	24,255 -185	-0.8%	-$5.95K	0.06%	105
2025 Q1	$841K	Hold	24,440	–	–	0.08%	95
2024 Q4	$841K	Buy	+24,440	New	+$840K	0.08%	95

Other funds holding HRMY

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return